Fig. 1From: Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up studyMACE during follow-up according to SAF median in patients with SAF < 2.0 and patients with SAF 2.0. p = 0.001Back to article page